BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.8.15//EN
X-ORIGINAL-URL:https://stage.utoronto.ca/
X-WR-CALNAME:CANSSI Ontario STAGE
X-WR-CALDESC:
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-210192abc6dd9b4f53d7ba4926461e86@stage.utoronto.ca
DTSTART:20141003T160000Z
DTEND:20141003T170000Z
DTSTAMP:20250624T234400Z
CREATED:20250624
LAST-MODIFIED:20260316
PRIORITY:5
SEQUENCE:77
TRANSP:OPAQUE
SUMMARY:STAGE ISSS: Paul Brennan
DESCRIPTION:\nJoin us for the next instalment of the STAGE International Speaker Seminar Series (ISSS) with\n\n\n\nPaul Brennan\n\n\n\nHead, Section of GeneticsHead, Genetic Epidemiology GroupInternational Agency for Research on Cancer (IARC/WHO)Lyon, France\n\n\n\nTalk Title:\n\n\n\nWhat proportion of oropharynx cancers are caused by HPV, and can we use HPV antibodies to identify them early? \n\n\n\nAbstract:\n\n\n\nOropharynx cancers are increasing in many parts of the world and are  set to become the leading HPV associated cancer in North America  by 2020. HPV16 E6 antibodies appear to be a sensitive and specific  marker for HPV associated oropharynx cancer and can be used to  estimate the proportion of oropharynx cancers caused by HPV in  different populations. They also appear to be present up to 15 years  before the onset of clinical symptoms, proving a possible biomarker for  accurate identification of individuals at very high risk of developing this  cancer. Finally, they are also potentially a strong marker of good clinical  response to treatment and survival.\n\n\n\nSpeaker Profile:\n\n\n\nPaul Brennan, PhD, is the Head of the Genetics Section of the International Agency for Research on Cancer (IARC/WHO), Lyon, France. The research focus of his group has two primary aims (i) identifying cancer predisposition genes through either genotyping or sequencing of very large numbers of cases and controls, and (ii) using biomarkers to help identify non-genetic risk factors for cancer, and even help identify early stage cancers. His group works with colleagues in many different parts of the world, with active field work studies underway in central and eastern Europe, central and south-east Asia, and Latin America\n\n\n\nSpeaker Poster:\n\n\n\n\n\n\n\nBrennan Paul Poster ( https://stage.utoronto.ca/wp-content/uploads/2025/07/Brennan-Paul-Poster.pdf )Download\n\n\n\nPhotography Disclosure:\n\n\n\nPhotographs and/or video may be taken of participants at STAGE events. These photos/videos are for the Program’s use only and may appear on its website, in printed brochures, or in other promotional or reporting materials. By attending STAGE events, you accept the possibility that you may be videotaped or photographed. If you have any concerns, please inform us by sending an e-mail to esther.berzunza@utoronto.ca\n
URL:https://stage.utoronto.ca/events/stage-isss-paul-brennan/
ORGANIZER;CN=CANSSI Ontario:MAILTO:esther.berzunza@utoronto.ca
CATEGORIES:CANSSI Ontario STAGE ISSS
LOCATION:4th Floor, Elm Wing, 555 University Ave, Toronto, ON
ATTACH;FMTTYPE=image/png:https://stage.utoronto.ca/wp-content/uploads/2025/06/Paul-Brennan.png
END:VEVENT
END:VCALENDAR
